We are live on ! Find out more
CAPTRUST Financial Advisors

CAPTRUST Financial Advisors Portfolio holdings

AUM $57.3B
1-Year Est. Return 18.32%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$14.6B
AUM Growth
+$2.55B
Cap. Flow
+$1.54B
Cap. Flow %
10.53%
Top 10 Hldgs %
22.66%
Holding
5,268
New
426
Increased
2,142
Reduced
1,399
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 14.83%
2 Financials 8.43%
3 Healthcare 7.26%
4 Industrials 6.5%
5 Consumer Discretionary 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVOP
4001
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$2K ﹤0.01%
95
-7
-7% -$160
ONEM
4002
DELISTED
1Life Healthcare
ONEM
$2K ﹤0.01%
99
+74
+296% +$1.44K
PTNR
4003
DELISTED
Partner Communications
PTNR
$2K ﹤0.01%
190
ATNX
4004
DELISTED
Athenex, Inc. Common Stock
ATNX
$2K ﹤0.01%
80
-7
-8% -$296
VLNS
4005
DELISTED
The Valens Company, Inc. Common Shares
VLNS
$2K ﹤0.01%
+950
New +$2.6K
UPH
4006
DELISTED
UpHealth, Inc.
UPH
$2K ﹤0.01%
100
MIC
4007
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$2K ﹤0.01%
470
-1,265
-73% -$8.27K
ETTX
4008
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$2K ﹤0.01%
+1,000
New +$2.7K
OACB.WS
4009
DELISTED
Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share
OACB.WS
$2K ﹤0.01%
1,782
CAS.WS
4010
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$2K ﹤0.01%
4,520
AFI
4011
DELISTED
Armstrong Flooring, Inc.
AFI
$2K ﹤0.01%
1,046
ALACR
4012
DELISTED
Alberton Acquisition Corp Rights
ALACR
$2K ﹤0.01%
5,000
KLDO
4013
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$2K ﹤0.01%
644
TLMD
4014
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$2K ﹤0.01%
1,490
+1,416
+1,914% +$2.84K
RESN
4015
DELISTED
Resonant Inc.
RESN
$2K ﹤0.01%
1,000
ZOM
4016
DELISTED
Zomedica Corp.
ZOM
$2K ﹤0.01%
7,500
-4,000
-35% -$1.8K
PRKR
4017
DELISTED
Parkervision Inc
PRKR
$2K ﹤0.01%
+2,000
New +$2K
PVCT
4018
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$2K ﹤0.01%
42,659
+20,202
+90% +$947
CNAF
4019
DELISTED
COMMERCIAL NATL FINL CORP PA
CNAF
$2K ﹤0.01%
124
YELL
4020
DELISTED
Yellow Corporation Common Stock
YELL
$2K ﹤0.01%
+172
New +$1.88K
CEO
4021
DELISTED
CNOOC Limited
CEO
$2K ﹤0.01%
+26
New +$2K
ACET icon
4022
Adicet Bio
ACET
$75.3M
$1K ﹤0.01%
+4
New +$687
AKYA
4023
DELISTED
Akoya BioSciences
AKYA
$1K ﹤0.01%
+90
New +$1.18K
ALGS icon
4024
Aligos Therapeutics
ALGS
$25.2M
$1K ﹤0.01%
+2
New +$729
AMRX icon
4025
Amneal Pharmaceuticals
AMRX
$5.78B
$1K ﹤0.01%
240
-83
-26% -$414

Similar funds

CAPTRUST Financial Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, CAPTRUST Financial Advisors held 5,268 positions worth $14.6B, up 21% from $12B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

CAPTRUST Financial Advisors deployed $1.54B of net new capital in Q4 2021, opening 426 new positions and adding to 2,142 existing holdings. Its largest new stake was Crescent Energy: 320,682 shares worth $4.07M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Ciena, an estimated $25.1M trimmed.

  • CAPTRUST Financial Advisors's largest Q4 2021 buy was Crescent Energy: 320,682 shares worth $4.07M.
  • CAPTRUST Financial Advisors added most to Vanguard Mega Cap Growth ETF in Q4 2021, an estimated $193M increase.
  • CAPTRUST Financial Advisors's biggest Q4 2021 reduction was Ciena, cutting an estimated $25.1M.
  • CAPTRUST Financial Advisors fully exited iShares iBonds Dec 2021 Term Corporate ETF in Q4 2021, selling an estimated $9.71M.
  • CAPTRUST Financial Advisors's ten largest holdings make up 23% of its $14.6B portfolio in Q4 2021.
  • CAPTRUST Financial Advisors opened 426 new positions and closed 238 in Q4 2021.
  • CAPTRUST Financial Advisors's portfolio value rose 21% quarter-over-quarter to $14.6B.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.